Julia Bolduc, MBA

Julia Bolduc, MBA has extensive work experience in the pharmaceutical and biotechnology industry. Julia most recently served as the Director, Regional Marketing (elacestrant) at Stemline Therapeutics, starting in October 2022. Prior to that, they worked at Gilead Sciences as the Associate Director, Regional Marketing-Opinion Leader Programming from July 2021 to October 2022. From November 2018 to July 2021, Julia held a role as an Oncology Account Manager at Immunomedics, where they successfully launched the first antibody drug conjugate (ADC) therapy for metastatic triple negative breast cancer. Additionally, they promoted FGFR mutated Urothelial Carcinoma therapy. Julia's career in the industry began at Novartis, where they worked as a Senior Oncology Sales Specialist from June 2003 to October 2018.

Julia Bolduc, MBA, earned their Bachelor of Arts (BA) degree in Human Resource Management from Michigan State University from 1998 to 2002. Julia later pursued a Master of Business Administration (MBA) degree in Business Administration and Management, General from Western Michigan University from 2005 to 2008.